Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.

NCT00801437 · clinicaltrials.gov ↗

COMPLETED

Status

457

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-angle

Interventions

DRUG: Xalacom

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.